methoxyhydroxyphenylglycol has been researched along with milnacipran in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Briley, M; Moret, C | 1 |
| Nakamura, J; Okamoto, K; Shinkai, K; Ueda, N; Yoshimura, R | 1 |
| Isaac, MT | 1 |
1 review(s) available for methoxyhydroxyphenylglycol and milnacipran
| Article | Year |
|---|---|
Treating depression with SNRIs: who will benefit most?
Topics: Cyclopropanes; Cytochrome P-450 CYP2D6; Depression; Humans; Meta-Analysis as Topic; Methoxyhydroxyphenylglycol; Milnacipran; Pharmacogenetics; Polymorphism, Genetic; Selective Serotonin Reuptake Inhibitors | 2008 |
2 other study(ies) available for methoxyhydroxyphenylglycol and milnacipran
| Article | Year |
|---|---|
Effects of milnacipran and pindolol on extracellular noradrenaline and serotonin levels in guinea pig hypothalamus.
Topics: Adrenergic beta-Antagonists; Animals; Cyclopropanes; Extracellular Space; Guinea Pigs; Hydroxyindoleacetic Acid; Hypothalamus; Kinetics; Male; Methoxyhydroxyphenylglycol; Milnacipran; Norepinephrine; Pindolol; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists | 1997 |
Associations between baseline plasma MHPG (3-methoxy-4-hydroxyphenylglycol) levels and clinical responses with respect to milnacipran versus paroxetine treatment.
Topics: Adult; Aged; Biomarkers; Cyclopropanes; Depressive Disorder; Female; Homovanillic Acid; Hospitals, University; Humans; Japan; Male; Methoxyhydroxyphenylglycol; Middle Aged; Milnacipran; Paroxetine; Patient Selection; Selective Serotonin Reuptake Inhibitors | 2004 |